Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
3.340
+0.030 (0.91%)
Jun 26, 2025, 12:40 PM - Market open

Puma Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
166150206196124408
Upgrade
Market Cap Growth
-42.52%-27.32%5.07%57.73%-69.53%19.67%
Upgrade
Enterprise Value
134139233233154420
Upgrade
Last Close Price
3.313.054.334.233.0410.26
Upgrade
PE Ratio
4.324.959.5498021.07--
Upgrade
Forward PE
7.9311.6210.5733.92--
Upgrade
PS Ratio
0.700.650.870.860.491.81
Upgrade
PB Ratio
1.691.633.859.07-50.81-68.55
Upgrade
P/TBV Ratio
3.423.65----
Upgrade
P/FCF Ratio
5.313.857.67-6.02561.16
Upgrade
P/OCF Ratio
5.293.857.63-6.02527.77
Upgrade
EV/Sales Ratio
0.580.610.991.020.611.86
Upgrade
EV/EBITDA Ratio
2.753.285.215.7412.22-
Upgrade
EV/EBIT Ratio
3.604.507.017.58119.32-
Upgrade
EV/FCF Ratio
4.303.598.68-7.45577.31
Upgrade
Debt / Equity Ratio
0.640.802.095.29-47.69-20.32
Upgrade
Debt / EBITDA Ratio
1.181.612.272.546.78-
Upgrade
Debt / FCF Ratio
1.981.914.15-5.65166.37
Upgrade
Asset Turnover
1.131.041.041.021.080.94
Upgrade
Inventory Turnover
8.108.1510.809.4712.0611.89
Upgrade
Quick Ratio
1.371.381.451.591.051.04
Upgrade
Current Ratio
1.531.541.571.731.281.28
Upgrade
Return on Equity (ROE)
51.41%41.60%57.54%0.02%--1042.30%
Upgrade
Return on Assets (ROA)
11.35%8.72%9.19%8.56%0.34%-7.93%
Upgrade
Return on Capital (ROIC)
14.53%11.69%13.82%15.35%0.70%-15.04%
Upgrade
Return on Capital Employed (ROCE)
34.00%26.40%25.40%21.20%1.10%-
Upgrade
Earnings Yield
23.00%20.22%10.48%0.00%-23.43%-14.71%
Upgrade
FCF Yield
18.83%25.96%13.04%-8.07%16.61%0.18%
Upgrade
Buyback Yield / Dilution
-3.60%-3.26%-5.83%-10.56%-2.69%-2.08%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q